Lawyers are investigating Ozempic lawsuits for patients with NAION, gastroparesis or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome.
Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type 2 diabetes. As we all know, Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis.
Until recently, the warning label for Ozempic did not correctly notify patients or doctors about the risk of these injuries. Anyone who suffered injuries after taking Ozempic may be able to get financial compensation for their injuries by filing a product liability lawsuit.
There are now lawsuits involving Ozempic, Rybelsus, Wegovy, Trulicity, and Mounjaro that, as of February 2024, is an MDL class action lawsuit.
